MUC1 cytoplasmic domain coactivates Wnt target gene transcription and confers transformation

Cancer Biology and Therapy

Volumn 2, Issue 6, 2003, Pages 702-706

  Huang, Lei ^a   Ren, Jian ^a   Chen, Dongshu ^b   Li, Yongqing ^b   Kharbanda, Surender ^b   Kufe, Donald ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b ILEX Products Inc   (United States)

Author keywords

Cyclin D1; MUC1; Tcf4; Transcription; Transformation; catenin

Indexed keywords

EID: 79960815298     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.2.6.610     Document Type: Article

References (30)

1. Polakis P. Wnt signaling and cancer. Genes Dev 2000; 14:1837-51.
2. Takeichi M. Cadherins: A molecular family important in selective cell-cell adhesion. Annu Rev Biochem 1990; 59:237-52.
3. Su L-K, Vogelstein B, Kinzler KW. Association of the APC tumor suppressor protein with catenins. Science 1993; 262:1734-7. (Pubitemid 24030097)
4. Rubinfeld B, Souza B, Albert I, Muller O, Chamberlain SH, Masiarz FR, et al. Association of the APC gene product with β-catenin. Science 1993; 262:1731-4. (Pubitemid 24030096)
5. Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P. Binding of GSK3β to the APC-β-catenin complex and regulation of complex assembly. Science 1996; 272:1023-6. (Pubitemid 26259322)
6. Peifer M, Polakis P. Wnt Signaling in oncogenesis and embryogenesis-a look outside the nucleus. Science 2000; 287:1606-9. (Pubitemid 30127755)
7. Wodarz A, Nusse R. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 1998; 14:59-88.
8. Yamamoto M, Bharti A, Li Y, Kufe D. Interaction of the DF3/MUC1 breast carcinoma-associated antigen and β-catenin in cell adhesion. J Biol Chem 1997; 272:12492-4. (Pubitemid 27203339)
9. Kufe D, Inghirami G, Abe M, Hayes D, Justi-Wheeler H, Schlom J. Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma 1984; 3:223-32. (Pubitemid 15184701)
10. Yin L, Kufe D. Human MUC1 carcinoma antigen regulates intracellular oxidant levels and the apoptotic response to oxidative stress. J Biol Chem 2003; 278:35458-64. (Pubitemid 37102316)
11. Li Y, Liu D, Chen D, Kharbanda S, Kufe D. Human DF3/MUC1 carcinoma-associated protein functions as an oncogene. Oncogene 2003; 22:6107-10. (Pubitemid 37175889)
12. Ligtenberg MJL, Vos HL, Gennissen AMC, Hilkens J. Episialin, a carcinoma-associated mucin, is generated by a polymorphic gene encoding splice variant with alternative amino termini. J Biol Chem 1990; 265:5573-8. (Pubitemid 20127185)
13. Gendler S, Taylor-Papadimitriou J, Duhig T, Rothbard J, Burchell JA. A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. J Biol Chem 1988; 263:12820-3.
14. Siddiqui J, Abe M, Hayes D, Shani E, Yunis E, Kufe D. Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen. Proc Natl Acad Sci USA 1988; 85:2320-3. (Pubitemid 24315883)
15. Li Y, Bharti A, Chen D, Gong J, Kufe D. Interaction of glycogen synthase kinase 3β with the DF3/MUC1 carcinoma-associated antigen and β-catenin. Mol Cell Biol 1998; 18:7216-24. (Pubitemid 28533041)
16. Li Y, Ren J, Yu W-H, Li G, Kuwahara H, Yin L, et al. The EGF receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and β-catenin. J Biol Chem 2001; 276:35239-42.
17. Li Y, Kuwahara H, Ren J, Wen G, Kufe D. The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1 carcinoma-associated antigen with GSK3β and β-catenin. J Biol Chem 2001; 276:6061-4.
18. Ren J, Li Y, Kufe D. Protein kinase C δ regulates function of the DF3/MUC1 carcinoma antigen in β-catenin signaling. J Biol Chem 2002; 277:17616-22. (Pubitemid 34967564)
19. Li Y, Chen W, Ren J, Yu W, Li Q, Yoshida K, et al. DF3/MUC1 signaling in multiple myeloma cells is regulated by interleukin-7. Cancer Biol Ther 2003; 2:187-93.
20. Li Y, Yu W-H, Ren J, Huang L, Kharbanda S, Loda M, et al. Heregulin targets γ-catenin to the nucleolus by a mechanism dependent on the DF3/MUC1 protein. Mol Cancer Res 2003; 1:765-75. (Pubitemid 37025595)
21. Wen Y, Caffrey T, Wheelock M, Johnson K, Hollingsworth M. Nuclear association of the cytoplasmic tail of MUC1 and β-catenin. J Biol Chem 2003(in press).
22. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, et al. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997; 275:1784-7. (Pubitemid 27136714)
23. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999; 398:422-6. (Pubitemid 29180374)
24. Ryo A, Nakamura M, Wulf G, Liou YC, Lu KP. Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nat Cell Biol 2001; 3:793-801. (Pubitemid 32842684)
25. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, et al. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 1997; 275:1787-90. (Pubitemid 27136715)
26. Arber N, Sutter T, Miyake M, Kahn SM, Venkatraj VS, Sobrino A, et al. Increased expression of cyclin D1 and the Rb tumor suppressor gene in c-K-ras transformed rat enterocytes. Oncogene 1996; 12:1903-8. (Pubitemid 26154662)
27. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 1994; 369:669-671 (Pubitemid 24199473)
28. Yu Q, Geng Y, Sicinski P. Specific protection against breast cancers by cyclin D1 ablation. Nature 2001; 411:1017-21. (Pubitemid 32612319)
29. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, et al. Identification of c-MYC as a target of the APC pathway. Science 1998; 281:1509-12. (Pubitemid 28425575)
30. Crawford HC, Fingleton BM, Rudolph-Owen LA, Goss KJ, Rubinfeld B, Polakis P, et al. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene 1999; 18:2883-91. (Pubitemid 29250878)